共 1114 条
[1]
Mariampillai K(2018)Development of a new classification system for idiopathic inflammatory myopathies based on clinical manifestations and myositis-specific autoantibodies JAMA Neurol 75 1528-1537
[2]
Granger B(2014)Risk of coronary artery disease in patients with idiopathic inflammatory myopathies: a systematic review and meta-analysis of observational studies Semin Arthritis Rheum 44 63-67
[3]
Amelin D(2016)Risk of myocardial infarction and ischaemic stroke in adults with polymyositis and dermatomyositis: a general population-based study Rheumatology (Oxford) 55 461-469
[4]
Guiguet M(2017)EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update Ann Rheum Dis 76 17-28
[5]
Hachulla E(2019)Optimizing dyslipidemia management for the prevention of cardiovascular disease: a focus on risk assessment and therapeutic options Curr Cardiol Rep 21 110-533
[6]
Maurier F(2008)Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised controlled trials of statins (vol 366, pg 1267, 2005) LANCET 371 2084-816
[7]
Meyer A(2016)Algorithms to identify statin intolerance in Medicare Administrative Claim Data Cardiovasc Drugs Ther 30 525-e646
[8]
Tohmé A(2012)Impact of statin discontinuation on mortality in patients with rheumatoid arthritis: a population-based study Arthritis Care Res 64 809-3058
[9]
Charuel JL(2019)2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines Circulation 140 e596-2152
[10]
Musset L(2016)2016 ESC/EAS guidelines for the management of dyslipidaemias Eur Heart J 37 2999-160